golimumab is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or purchase a subscription.

Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:

Emergency Central

-- The first section of this topic is shown below --

General

Pronunciation:
go-li-mu-mab


Trade Name(s)

  • Simponi
  • Simponi Aria
  • Simponi IV Canadian Tradename

Ther. Class.
antirheumatics

Pharm. Class.
dmards
monoclonal antibodies
anti tnf agents

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - golimumab ID - 109523 A1 - Quiring,Courtney, AU - Sanoski,Cynthia A, AU - Vallerand,April Hazard, BT - Davis's Drug Guide UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109523/all/golimumab PB - F.A. Davis Company ET - 16 DB - Emergency Central DP - Unbound Medicine ER -